Pharma Business Daily
Claim your FREE trial subscription!


Diagnostics:

Innovations in Diagnostics

Business Insights
Market Briefing  September 2006

Single-user PDF - USD 2875.00  


Table of Contents

Innovations in Diagnostics: Next generation molecular and point-of-care diagnostics driving personalized healthcare

The global diagnostics market is undergoing radical change; novel technologies driven by miniaturization and advances in genomics will enhance the role of diagnostics in the healthcare market, allowing more tests to be performed at the point-of-care and facilitating the shift towards personalized medicine. “Innovation in Diagnostics” examines the advances in the rapidly growing field of molecular technologies that are enabling personalized healthcare to move into mainstream medicine.

New opportunities in infectious disease testing, molecular oncology and pharmacogenomics are explored in detail, enabling you to understand the forces that are driving in vitro diagnostics (IVDs) into centre stage of the healthcare arena. Understand the changing relationship between IVD companies and the pharmaceutical industry, assess the convergence of IVDs and medical imaging, and develop an understanding of new technologies that will influence diagnostic product development and drug development programs.



For full details, please email jenniferc@cmsinfo.com

Order Form




CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel:     +44 (0)1494 771734
Fax:   +44 (0)1494 778994
e-mail: Jennifer Cowlard
copyright © 2008 all rights reserved

For more information about us, visit CMSinfo.

footer bar